Market Overview

Benzinga's Top Pre-Market Gainers

Related KYTH
Kythera Biopharmaceuticals, Inc. (KYTH) in Focus: Stock Surges 9.9 % - Tale of the Tape
What Falling Estimates & Price Mean for Kythera (KYTH) - Tale of the Tape
Related BCRX
UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst Pharmaceuticals on Positive Expectations for Oral HAE Drug
Benzinga's Top Initiations

Kythera Biopharmaceuticals (NASDAQ: KYTH) shares jumped 28.69% to $43.15 in pre-market trading after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.

Huntsman (NYSE: HUN) surged 8.05% to $20.68 in the pre-market session after the company announced its plans to buy Rockwood Holdings' (NYSE: ROC) Performance Additives and Titanium Dioxide businesses for $1.1 billion in cash.

BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.

Discover Financial Services (NYSE: DFS) soared 4.92% to $54.43 in the pre-market trading. Discover Financial's PEG ratio is 1.26.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Most Popular

Related Articles (BCRX + DFS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free